The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
The first U.S. patients have been dosed in a clinical trial testing whether four experimental mRNA vaccine candidates can prevent infection with the ...
read more
Review the latest news and information on the Coronavirus Pandemic.
read more
INOVIO has entered into an agreement to expand its manufacturing partnership with the German contract manufacturer Richter-Helm BioLogics GmbH & Co. ...
read more
Lipocine announced the FDA has accepted the Company's IND to initiate a Phase 2 study to evaluate LPCN 1148 for liver cirrhosis in adult male ...
read more
Review the latest news and information on the Coronavirus Pandemic.
read more
Montefiore Health System, Albert Einstein College of Medicine and NYU Langone have launched a new clinical trial to study if convalescent plasma, ...
read more
Review the latest news and information on the Coronavirus Pandemic.
read more
Shionogi has initiated a collaborative research effort to identify drugs active against COVID-19 with the Hokkaido University Research Center for ...
read more
The CEPI and the EIB signed an advisory agreement to collaborate on the development of innovative financing schemes to support vaccines development.
read more
Review the latest news and information on the COVID-19 Pandemic.
read more
Trio and Ajinomoto Bio-Pharma announced a development collaboration agreement to evaluate AJICAP for the development of TDCs.
read more
INTERPHEX has announced the next edition of the trade show previously postponed to July 2020, will now take place April 20-22, 2021 at the Javits ...
read more
Review the latest news and information on the COVID-19 Pandemic.
read more
Wednesday, April 29, 2020
Romark will initiate two clinical trials of its investigational new drug candidate NT-300 for prevention of COVID-19 and other viral respiratory ...
read more
Wednesday, April 29, 2020
Santhera Pharmaceuticals has entered into a collaboration agreement with Cold Spring Harbor Laboratory to investigate the potential of lonodelestat.
read more